Lung Cancer EVAN Study: Adjuvant Erlotinib Superior to Chemotherapy for R0-Stage III EGFR+ NSCLC Mar 29, 2023
Lung Cancer ORIENT-11 Asian Results: Applicability in West according to ICH- E5 Framework Mar 29, 2023
